Pharmaceuticals, Biotechnology and Life Sciences
Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of…
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026Company plans FDA discussion in Q3 2026…
Current Clinical Trial Focus is MSS Colorectal Cancer, Ovarian Clear-Cell Carcinoma, and Soft-Tissue SarcomaDENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) —…
As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug.…
– Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine – OXFORD, United Kingdom and…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J, Aug. 25, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…
Utah Governor Spencer Cox opens 190,000-square-foot buildingNusano platform capable of producing more than 40 different radioisotopes for healthcare and industryNew…
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for…
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce…